Address

Atlas Venture
25 First Street
Suite 303
Cambridge, MA 02141
United States

Open map


Recent investment activity

KANDO id: 24121

Corporate information

Founders
Registration country

Company type

Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US.

Funding rounds

Top investment portfolio themes

Actual initial investment stage
N/A (53)
Series A (28)
Seed (9)
Other (1)

Investment activity status
Active investor

Selected investments

Displaying 101 - 116 of 116
Profile Country Date Funding
Translate Bio N/A Initial investment
Tribotek Inc Electrical interconnect technology company. N/A Initial investment
Ubiquisys Ltd Develops convergence solutions that enable mobile operators to speed up and fully benefit from fixed mobile substitution Venture Follow-on investment
Ubiquisys Ltd Develops convergence solutions that enable mobile operators to speed up and fully benefit from fixed mobile substitution Venture Follow-on investment
Ubiquisys Ltd Develops convergence solutions that enable mobile operators to speed up and fully benefit from fixed mobile substitution Series B Follow-on investment
Ubiquisys Ltd Develops convergence solutions that enable mobile operators to speed up and fully benefit from fixed mobile substitution Series A Initial investment 12,000,000 (USD 12,000,000)
Veracode Inc Provider of the world’s leading Application Risk Management Platform. N/A Initial investment 7,500,000 (USD 7,500,000)
Vermeer Technologies Inc Publishing software company. N/A Initial investment
VideoIQ Inc Intelligent video surveillance company. Series A Initial investment 8,000,000 (USD 8,000,000)
VirtualLogix Inc Global leader in real-time virtualization™ technology for connected devices. N/A Initial investment
Vitae Pharmaceuticals Inc Drug discovery company developing optimized drugs using proprietary computational drug design platform. Other Initial investment 15,000,000 (USD 15,000,000)
WaveSmith Networks Inc Designs and develops optical network equipment for use in the communications sector. N/A Initial investment
Xtera Communications Inc N/A Initial investment
Zafgen Inc The world’s first biopharmaceutical company dedicated to developing novel obesity therapeutics. Series A Initial investment 5,180,000 (USD 5,180,000)
Zinwave Ltd Global provider of reliable in-building wireless coverage solutions Series A Initial investment 7,640,000 (USD 7,640,000)
Zoopla Ltd UK online real estate listings site. Series B Initial investment 5,440,000 (USD 5,440,000)

Current team

Past employees

Selected Products / Customers

Financials